Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Mayo Clinic | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The study examines and illustrates the utility of utilizing actigraphic measurements to assess treatment response.
Actigraphic measurements, repeated verbal fluency and multi-symptom operationally defined observations will be recorded for an 11 to 12 day baseline period and continued following neurosurgical tumor resection until a repeat MRI is completed three months after the procedure.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Actigraphic Neurosurgical Outcomes | Experimental | Actigraphic measurements that will be obtained by attaching the actigraphic watch device to the individual's non-dominant wrist and operationally defined repeated observational measurements. All measurements will continue through a baseline period and continue through the identified post surgical period. Actigraphic measurements will occur every 30 seconds with brief periods of non-measurement during the actual neurosurgical procedure and periods when the actigraphic device has reached storage capacity (approximately every 22 days) when data is retrieved and the device prepared resume measurements. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Re-section of a large left anterior cranial fossa meningioma | Procedure | Neurosurgical re-section of an incidental large left anterior cranial fossa meningioma |
|
| Measure | Description | Time Frame |
|---|---|---|
| Pre and Post Actigraphic and Systematic Observation Scale measurements | March 15, 2009-June 20, 2009 |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Bill J Duke, M.A., Ph.D. | Child Psychopharmacology Institute | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Child Psychopharmacology Institute | Fargo | North Dakota | 58103 | United States |
Not provided
| ID | Term |
|---|---|
| D012893 | Sleep Wake Disorders |
| D010146 | Pain |
| ID | Term |
|---|---|
| D009422 | Nervous System Diseases |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D056044 | Actigraphy |
| ID | Term |
|---|---|
| D008991 | Monitoring, Physiologic |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
| D061725 | Accelerometry |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| D001523 | Mental Disorders |
| D008919 |
| Investigative Techniques |